Compounds > sofosbuvir
Page last updated: 2024-08-25

sofosbuvir and Psoriasis

sofosbuvir has been researched along with Psoriasis in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's7 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Elfert, AA1
Enomoto, M; Kawada, N; Tamori, A; Tateishi, C; Tsuruta, D1
Di Cesare, A; Lazzeri, L; Pescitelli, L; Prignano, F; Ricceri, F; Tripo, L1
Barone, CR; Bonamigo, RR; Boza, JC; Oliveira, FB; Pires, GC; Rossi, SD; Silva, M1
Ismail, WA; Yousef, AE1
Liu, P; Wang, Y1
Heppt, F; Sticherling, M1

Other Studies

7 other study(ies) available for sofosbuvir and Psoriasis

ArticleYear
Sustained improvement of psoriasis associated with HCV after virologic response to sofosbuvir/ribavirin.
    Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology, 2017, Volume: 18, Issue:4

    Topics: Adolescent; Antiviral Agents; Hepatitis C; Humans; Male; Psoriasis; Ribavirin; Sofosbuvir

2017
Remission of Psoriasis After Treatment of Chronic Hepatitis C Virus Infection With Direct-Acting Antivirals.
    Annals of internal medicine, 2018, 05-01, Volume: 168, Issue:9

    Topics: Aged, 80 and over; Antiviral Agents; Benzimidazoles; Fluorenes; Hepatitis C, Chronic; Humans; Male; Psoriasis; Remission Induction; Sofosbuvir; Uridine Monophosphate

2018
Safety and efficacy of HCV eradication during etanercept treatment for severe psoriasis.
    Dermatologic therapy, 2018, Volume: 31, Issue:4

    Topics: Aged; Antiviral Agents; Carbamates; Etanercept; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Immunosuppressive Agents; Male; Psoriasis; Pyrrolidines; Severity of Illness Index; Sofosbuvir; Treatment Outcome; Tumor Necrosis Factor-alpha; Valine

2018
Direct-acting antiviral drugs are triggers for psoriasis: report of three cases.
    International journal of dermatology, 2018, Volume: 57, Issue:10

    Topics: Adult; Aged; Antiviral Agents; Carbamates; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Imidazoles; Male; Middle Aged; Psoriasis; Pyrrolidines; Ribavirin; Simeprevir; Sofosbuvir; Symptom Flare Up; Valine

2018
Effect of sofosbuvir plus daclatasvir for treatment of chronic hepatitis C on patients with psoriasis.
    European journal of gastroenterology & hepatology, 2019, Volume: 31, Issue:8

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Carbamates; Cross-Sectional Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Male; Middle Aged; Prospective Studies; Psoriasis; Pyrrolidines; Quality of Life; Sofosbuvir; Treatment Outcome; Valine; Viral Load; Young Adult

2019
A case of erythema multiforme drug eruption associated with erythrodermic psoriasis induced by sofosbuvir and daclatasvir.
    Journal of clinical pharmacy and therapeutics, 2017, Volume: 42, Issue:1

    Topics: Carbamates; Drug Eruptions; Erythema Multiforme; Humans; Imidazoles; Male; Middle Aged; Psoriasis; Pyrrolidines; Sofosbuvir; Valine

2017
Psoriasis as a Manifestation of an Immune Reconstitution in Two Patients with Hepatitis C Treated with Ledipasvir/Sofosbuvir.
    Acta dermato-venereologica, 2017, 04-06, Volume: 97, Issue:4

    Topics: Adult; Aged; Antiviral Agents; Benzimidazoles; Combined Modality Therapy; Dermatologic Agents; Disease Progression; Fluorenes; Hepatitis C; Humans; Male; Psoriasis; Risk Factors; Severity of Illness Index; Sofosbuvir; Treatment Outcome; Ultraviolet Therapy; Uridine Monophosphate

2017